The regulatory DNA sequence elements that control the expression of the hepatitis B virus major surface antigen gene in the hepatoblastoma cell line HepG2 were analyzed by using transient transfection assays. In this system, the hepatitis B virus enhancer increases transcription from the surface antigen promoter approximately twofold. The promoter elements regulating the expression of this gene are within a 200-nucleotide sequence located immediately upstream of the transcription initiation sites. The promoter consists of an 85-nucleotide distal element which increases transcription from the surface antigen gene by two-to fourfold and a proximal element of approximately 115 nucleotides which is essential for transcriptional activity. The proximal and distal promoter elements were shown to bind factors present in HepG2 nuclear extracts, which is consistent with the regulatory role demonstrated for these sequences. The regulatory role of these promoter sequences in the hepatocellular carcinoma cell lines PLC/PRF/5 and Hep3B was also demonstrated, indicating similar transcriptional regulation of the surface antigen gene in each of these differentiated hepatoma cell lines.
The hepatitis B virus (HBV) genome is a circular 3.2-kilobase partially double-stranded DNA molecule (24) . In the virion, the genome is enclosed in a 27-nm nucleocapsid of HBV core antigen which is enveloped by a lipoprotein coat comprising cellular lipid and HBV surface antigen (35) . During HBV infection, 3.5-, 2.4-, 2.1-, and possibly 0.7-kilobase RNAs are transcribed from the viral genome (4, 5, 16, 18, 32, 42) . These transcripts code for the nucleocapsid polypeptides and putative HBV polymerase, the large surface antigen polypeptide, the middle and major surface antigen polypeptides, and possibly the X-gene product, respectively (35) . The regulatory sequence elements that control the expression of these transcripts have been characterized in a variety of cell lines. These analyses have indicated that the HBV genome contains a transcriptional enhancer element located between the 3' end of the surface antigen gene and the 5' end of the X-gene open reading frame (ORF) (1, 3, 7, 13, 14, 17, 29, 36, 40) . In addition, regulatory sequence elements have been identified near the transcription initiation sites of each of the HBV RNAs (9, 15, 19, 23, 28, 30, 31, 37) .
Recently, it has been demonstrated that certain hepatoma cell lines have the capacity to complete all the steps of the HBV replication cycle subsequent to viral entry into the cell (6, 26, 34, 38, 41) . Despite the relatively low efficiency of viral production in this system, this suggests that the transcriptional regulatory mechanisms which operate during infection of hepatocytes in vivo may be most precisely mimicked in these hepatoma cell lines. In addition, it is apparent that the cis-acting regulatory sequences of the nucleocapsid, large surface antigen, and X genes are located in regions of the HBV genome that code for a single polypeptide, whereas the regulatory sequences of the major surface antigen gene are located in a region of the genome * Corresponding author.
t Publication 5869-BCR from the Research Institute of Scripps Clinic, La Jolla, CA 92037. where the pre-S and polymerase ORFs overlap (35) . The requirements to conserve both of these ORFs such that they encode functional polypeptides presumably places restrictions on the nucleotide sequences which interact with the transcription factors involved in regulating the expression of the major surface antigen gene.
For these reasons, a detailed analysis of the transcriptional regulatory sequence elements which control the expression of the major surface antigen gene was performed by using transient transfection assays in the hepatoblastoma cell line HepG2. This analysis indicated that the role of the HBV enhancer in the regulation of the major surface antigen gene was limited to an approximately twofold increase in transcription. Sequence elements approximately 200 nucleotides immediately upstream of the transcription initiation sites were necessary for high-level expression from this promoter, whereas approximately 115 nucleotides were essential for transcriptional activity. Similar results were obtained with the hepatocellular carcinoma cell lines PLC/ PRF/5 and Hep3B. The major surface antigen promoter elements defined in this study for HBV DNA (subtype ayw) differ from those previously identified for HBV DNA (subtype adw2) (9), suggesting possible subtype-specific regulation of this transcription unit.
MATERIALS AND METHODS
Plasmid constructions. The various steps in the cloning of the plasmid constructs used in the transfection experiments were performed by standard techniques (21) . The HBV sequences in these constructions were derived from the plasmid pCP10, which contains two copies of the HBV genome (subtype ayw) cloned into the EcoRI site of pBR322 (12) . The plasmid Sp (Fig. 1) in this and subsequent constructs is located 157 nucleotides 3' to the surface antigen transcription initiation site (see Fig.  7 ). Therefore, the plasmid Sp contains one complete HBV genome located directly 5' to the promoterless chloramphenicol acetyltransferase (CAT) reporter gene such that the expression of the CAT gene is governed by the HBV major surface antigen promoter. The plasmid SpX (Fig. 2) lines PLC/PRF/5 (Alexander cells) and Hep3B were grown in Dulbecco modified Eagle medium containing 10% fetal calf serum at 37°C in 5% C02-air and were transfected as previously described (22) . The transfected DNA mixture comprised 15 p.g of an Sp or SpX series plasmid and 1.5 Rg of pSV2AL-AA5' (10) , which served as an internal control for transfection efficiency. pSV2AL-AA5' directs the expression of the luciferase gene by using the simian virus 40 early promoter. Cell extracts were prepared 40 to 48 h after transfection and were assayed for luciferase and chloramphenicol acetyltransferase activity as previously reported (10) .
RNA isolation and Si nuclease analysis. RNA was isolated from transfected cells by the acid guanidinium thiocyanatephenol-chloroform extraction method (8) . The SI nuclease protection analysis was performed by standard methods 20 ,ug of single-stranded calf thymus DNA per ml and 300 U of S1 nuclease and subsequent incubation for 30 min at 37°C. The digestion mixtures were precipitated with ethanol and analyzed by 6% urea-acrylamide sequencing gel electrophoresis and autoradiography.
DNase I footprinting. Nuclear extracts were prepared from HepG2 cells essentially as described previously (11) . All operations were performed at 0 to 4°C. Cells were harvested from culture and centrifuged for 5 min at 2,000 rpm in a Sorvall RT6000 centrifuge. Pelleted cells were washed once in 20 ml of 10 mM sodium phosphate (pH 6.8)-0.14 M NaCl-1.5 mM MgCl2 by suspension and recentrifugation for 5 min at 2,000 rpm. The cell pellet was suspended in 5 volumes of hypotonic buffer (10 mM Tris hydrochloride [pH 7.9], 10 mM KCl, 1.5 mM MgCl2, 0.5 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride) and allowed to stand for 10 min. Cells were collected by centrifugation for 5 min at 2,000 rpm, suspended in 2 volumes of hypotonic buffer, and lysed by 10 to 15 strokes of an all-glass Dounce homogenizer (B-type pestle). Cell lysis was more than 90%. The homogenate was centrifuged for 10 min at 3,000 rpm in a Sorvall SS34 rotor, and the supernatant was carefully poured off to leave a loose nuclear pellet. This was recentrifuged for 20 min at 15,000 rpm in the SS34 rotor, and the supernatant was decanted. The pellet was suspended in 2.5 volumes of nuclear extraction buffer (20 mM (Fig. 1) , comprised the complete sequence of the HBV genome. A series of 5' deletions of the HBV genome were tested for their effects on the transcriptional activity of the surface antigen promoter (Fig. 1) . Transcriptional activity was not lost when sequences from nucleotides 130 to 3055 were deleted, indicating that a minimal promoter element exists between nucleotides 3056 and 133'. In addition, the plasmid SpAl30-3055/3170-133' showed only a twofold reduction in relative CAT activity compared with the plasmid SpA130-3055, indicating that the minimal promoter element is present between nucleotides 3056 and 3169. The difference in relative CAT activity between these two constructs is probably not due to the deletion of promoter sequences but results from the deletion of 146 nucleotides (nucleotides 3170 to 133') which are transcribed into the CAT RNA coded for by the plasmid SpA130-3055 but have been deleted from the CAT transcript expressed from the plasmid SpA130-3055/ 3170-133'.This additional deletion shortens the 5' untranslated region of this transcript, which may influence its stability or efficiency of translation. Therefore, the minimal promoter element is located between -103 and + 11 relative to a predominant transcriptional initiation site (see Fig. 7) identified at approximately nucleotide 3159 (Fig. 4) S1 nuclease, the protected fragments were resolved in 6% urea-acrylamide sequencing gels and subjected to autoradiography.
The role of the HBV enhancer sequence in the regulation of the expression from the surface antigen promoter appears to be limited. There was only a twofold difference in relative CAT activity between the transcriptional activity of the plasmids SpA130-1070 and SpA130-1238, which differ only by a 138-nucleotide sequence which includes the HBV enhancer sequence (29) . Interpretation of this result has been complicated by the recent observation that the product of the X gene can transactivate the simian virus 40 early promoter in HepG2 cells (39) . Measurements of the absolute amounts of luciferase activity produced by cotransfection of pSV2AL-AA5' with plasmids of the SpA series suggest that transactivation of the simian virus 40 early promoter by the X-gene product, if it occurs in our system, is limited to only a two-to fourfold increase in the presence of plasmids Sp through SpAl130-1374 (data not shown). This modest effect does not significantly alter the interpretation of this deletion analysis. In addition, experiments using the mouse metallothionein promoter to transcribe the luciferase gene as an internal control produced results similar to those using pSV2AL-AA5' (data not shown).
The sequence elements that regulate the expression of the surface antigen gene were further characterized by analyzing the transcriptional activity of the SpX series of plasmids (Fig. 2) . These deletions differ from the Sp series of plasmids in that the CAT gene has been inserted into the surface antigen transcription unit such that CAT should be encoded by an RNA which is identical to the 2.1-kilobase transcript produced during infection except that it contains the CAT ORF inserted 28 nucleotides 5' to the major surface antigen initiation codon. In addition, the complete series of constructs contains the X gene and the regulatory sequences necessary for its expression (31, 37) . This deletion analysis revealed that the same minimal promoter element located within 103 nucleotides 5' to the transcriptional initiation site was essential for promoter activity (SpXA1987-3055).
The contribution of the HBV enhancer sequence to the transcriptional activity from the surface antigen promoter was further characterized by deleting this sequence from the Sp and SpX plasmids (Fig. 3) (Fig. 1 to 3 ). Direct determination of the abundance of correctly initiating transcripts was performed by Si nuclease protection analysis of RNA isolated from HepG2 cells transfected with various plasmids to confirm these observations (Fig. 4) (Fig. 5) . The positions of these protected regions were accurately determined by comparison with the sequencing reaction products of an unrelated DNA of known sequence resolved on the same gel. The positions of these regions which were protected from DNase I digestion by factors present in the HepG2 nuclear extracts were compared with the locations of the various promoter deletion breakpoints which influence the transcriptional activity of the surface antigen promoter in the transient transfection assays (see Fig. 7 ).
It is apparent that the factor(s) responsible for footprint which are 5' to the deletion breakpoint at 3055. This therefore suggests that the transcription factors which interact with regions I and II are not essential for transcriptional activity from the surface antigen gene but they may be involved in influencing its activity. Footprint region III comprises two protected regions on the short strand, IIISa and IIISb, and one protected region on the long strand, IIIL. It should be noted that the separation of the protected regions between nucleotides 3032 and 3091 into footprint regions II and III is based on the minimal essential promoter region being functionally defined between nucleotides 3056 and 3169 (Fig. 1) . These designations are not meant to indicate the location of regions protected from DNase I digestion by specific individual transcription factors. The minimal essential surface antigen gene promoter region also includes footprint region IV, which is located at the extreme end of the 5' untranslated region of the longest surface antigen transcript. The factors which bind to regions III and IV are likely to be involved in regulating the transcriptional activity of the surface antigen promoter. (Fig. 6) . The results indicate that sequences between nucleotides 2971 and 3055 influence the level of transcription from the surface antigen promoter, increasing the activity threeto fourfold. In addition, sequences within 103 nucleotides of the transcriptional initiation site were essential for minimal promoter activity (plasmid SpA130-3055). These results indicate that the same sequences are involved in the regulation of the HBV major surface antigen gene in the three differentiated hepatoma cell lines examined.
DISCUSSION
The HBV genome (subtype ayw) comprises 3,182 nucleotides and contains all the information necessary for the production of infectious virions after its introduction into the differentiated hepatoblastoma cell line HepG2 by transfection (33, 34) . The small size of the genome and the observation that every nucleotide resides in at least one ORF suggests that the sequence elements which regulate the expression of the HBV genes might possess limited complexity. In an attempt to examine this possibility, the regulatory sequence elements which are present in the complete HBV genome and which influence the transcriptional activity of the major surface antigen gene promoter in differentiated hepatoma cell lines were characterized.
In HepG2 cells, it was apparent that the HBV enhancer had little effect on the transcriptional activity of the major surface antigen promoter. This was the case whether the enhancer sequence was located 5' to or within the CAT transcription unit (Fig. 1 and 3) . In each case, the position of the enhancer sequence corresponded to its normal location in the HBV genome. The influence of the enhancer sequence on the activity of the surface antigen gene promoter has been investigated in a variety of different systems (1, 3, 7, 14) . In two cases (1, 7), the presence of the enhancer resulted in increased transcriptional activity from the surface antigen promoter by 20-to 60-fold in the various hepatoma cell lines used in these studies. However, these results were obtained by moving the enhancer sequence from its normal position in the HBV genome. The relocation of the enhancer may increase its ability to influence the transcriptional activity of the surface antigen promoter. Consistent with this possibility, deletion of the enhancer sequence from the surface antigen transcription unit has been shown to result in a very modest decrease in transcriptional activity from the surface antigen promoter in HepG2 cells (3). It has also been suggested that the enhancer may increase transcription from the surface antigen promoter in a cell-specific manner (14) . The activity of the surface antigen promoter in the hepatoma cell line PLC/PRF/5 was shown to be independent of the enhancer sequence, whereas the enhancer sequence increased transcription from this promoter approximately 30- fold in the hepatoma cell line SK-Hepl (14) . Our results are compatible with the suggestion that the enhancer sequence, when located at its normal location in the HBV genome, may only slightly modulate the level of expression from the surface antigen promoter in HepG2 cells. In addition, it is apparent that transcriptional activity from the other HBV promoters does not significantly influence the transcriptional activity from the surface antigen promoter ( Fig. 1 and 2) .
The detailed deletion analysis of the HBV major surface antigen promoter indicated that correctly initiated transcription required only 103 nucleotides of 5'-flanking sequences. However, an additional 85 nucleotides (-104 to -188 relative to the transcription initiation site) of 5'-flanking sequence immediately adjacent to this element increased the transcriptional activity of the surface antigen promoter approximately fourfold (Fig. 1, 6, and 7) . These results obtained from transient transfection assays define a regulatory region which was shown to bind several nuclear factors isolated from HepG2 cells (Fig. 5) . The footprint region I contains the consensus sequence TGG(N)67GCCAA, which has been shown to bind the transcription factor NF1 (28) . Since all but the first nucleotide of this consensus sequence is retained in the plasmid SpA130-2970, it is possible that this or a related factor is involved in modulating the transcriptional activity of the surface antigen promoter. It is also likely that the factor(s) responsible for footprint region II is also involved in the modulation of the activity of the surface antigen promoter, whereas the factors responsible for footprint regions III and IV may represent essential transcription factors, since they bind the minimal promoter region -103 to +11 (Fig. 7) .
The promoter elements defined in this analysis differ significantly from the surface antigen regulatory sequences defined previously in PLC/PRF/5 cells (9). In the previous report (9) , only 81 nucleotides 5' to the transcription initiation site (nucleotide 3159 [ Fig. 7] ) were essential for maximum activity of the surface antigen promoter. Deletion of sequences to within 26 nucleotides of the transcription initiation site resulted in only a threefold reduction in promoter activity (9) . In contrast, in our analysis 188 nucleotides of 5'-flanking sequences were required for maximal promoter activity, and when this was deleted to 103 nucleotides there was a fourfold reduction in activity. Activity was completely lost when the 5'-flanking sequence was deleted to 36 nucleotides. These observations suggest these two HBV surface antigen promoters might be regulated differently. Since this analysis was performed with HBV DNA (subtype ayw) and the previous analysis used HBV DNA (subtype adw2), it is possible that different subtypes of HBV have evolved to the extent where they now possess distinct mechanisms of gene regulation. Comparison of the HBVayw and HBVadw2 sequences in the surface antigen promoter region reveals nucleotide differences in footprint regions I to III, suggesting the possibility that transcription factors might distinguish between these subtype-specific sequence elements. A more detailed analysis of the sequences involved in the regulation of the surface antigen promoter of these two HBV subtypes will be required to resolve this issue.
